UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The National Lung Matrix Trial of personalized therapy in lung cancer

Nature (London), 2020-07, Vol.583 (7818), p.807-812

2020

Volltextzugriff (PDF)

The Effects of GCSF Primary Prophylaxis on Survival Outcomes and Toxicity in Patients with Advanced Non-Small Cell Lung Cancer on First-Line Chemoimmunotherapy: A Sub-Analysis of the Spinnaker Study

International journal of molecular sciences, 2023-01, Vol.24 (2), p.1746

2023

Volltextzugriff (PDF)

Clinically Significant Differences in Ki-67 Proliferation Index Between Primary and Metastases in Resected Pancreatic Neuroendocrine Tumors

Pancreas, 2017-11, Vol.46 (10), p.1354-1358

2017

Volltextzugriff (PDF)

Evaluating niraparib versus active symptom control in patients with previously treated mesothelioma (NERO): a study protocol for a multicentre, randomised, two-arm, open-label phase II trial in UK secondary care centres

BMJ open, 2023-11, Vol.13 (11), p.e073120-e073120

2023

Volltextzugriff (PDF)

Immunotherapy-related adverse events in real-world patients with advanced non-small cell lung cancer on chemoimmunotherapy: a Spinnaker study sub-analysis

Frontiers in oncology, 2023-05, Vol.13, p.1163768-1163768

2023

Volltextzugriff (PDF)

Newly qualified doctors' views about whether their medical school had trained them well: questionnaire surveys

BMC medical education, 2007-10, Vol.7 (1), p.38-38, Article 38

2007

Volltextzugriff (PDF)

Tumour diameter is not reliable for management of non-secreting pancreatic neuroendocrine tumours

Endocrine Connections, 2017-11, Vol.6 (8), p.876-885

2017

Volltextzugriff (PDF)

'It gives you an understanding you can't get from any book.' The relationship between medical students' and doctors' personal illness experiences and their performance: a qualitative and quantitative study

BMC medical education, 2007-12, Vol.7 (1), p.50-50, Article 50

2007

Volltextzugriff (PDF)

Oncology and medical education-past, present and future

Ecancermedicalscience, 2016, Vol.10, p.ed54-ed54

Cave, Judith

2016

Volltextzugriff (PDF)

Explicitly linking teaching and assessment of communication skills

Medical teacher, 2007-05, Vol.29 (4), p.317-322

2007

Volltextzugriff (PDF)

Outcome and Biomarker Analysis from a Multicenter Phase 2 Study of Ipilimumab in Combination with Carboplatin and Etoposide as First-Line Therapy for Extensive-Stage SCLC

Journal of thoracic oncology, 2016-09, Vol.11 (9), p.1511-1521

2016

Volltextzugriff (PDF)

A randomised phase II trial of niraparib versus active symptom control in patients with previously treated mesothelioma: NERO

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.TPS8600-TPS8600

2023

Volltextzugriff (PDF)

The assessment of Ki-67 as a prognostic marker in neuroendocrine tumours: a systematic review and meta-analysis

Journal of clinical pathology, 2016-07, Vol.69 (7), p.612-618

2016

Volltextzugriff (PDF)

THE COMPETENT NOVICE: Dealing with complaints

BMJ. British medical journal (International ed.), 2008-02, Vol.336 (7639), p.326

International edition, 2008

Volltextzugriff (PDF)

Utility of KI-67 as a prognostic biomarker in pulmonary neuroendocrine neoplasms: a systematic review and meta-analysis

BMJ open, 2022-03, Vol.12 (3), p.e041961-e041961

2022

Volltextzugriff (PDF)

Ethnic stereotypes and the underachievement of UK medical students from ethnic minorities: qualitative study

BMJ, 2008-09, Vol.337 (aug18 1), p.a1220-a1220

International edition, 2008

Volltextzugriff (PDF)

Easing the transition from student to doctor: How can medical schools help prepare their graduates for starting work?

Medical teacher, 2009-05, Vol.31 (5), p.403-408

2009

Volltextzugriff (PDF)

NET-02 final results: A randomised, phase II trial of liposomal irinotecan (nal-IRI)/5-fluorouracil (5-FU)/folinic acid or docetaxel as second-line (2L) therapy in patients (pts) with progressive poorly differentiated extrapulmonary neuroendocrine carcinoma (PD-EP-NEC)

Journal of clinical oncology, 2023-02, Vol.41 (4_suppl), p.646-646

2023

Volltextzugriff (PDF)

An open-label, multicenter phase I/IIa study evaluating the safety and clinical activity of clonal neoantigen reactive T cells in patients with advanced non-small cell lung cancer (CHIRON)

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.TPS9138-TPS9138

2021

Volltextzugriff (PDF)

Recent advances in the molecular landscape of lung neuroendocrine tumors

Expert review of molecular diagnostics, 2019-04, Vol.19 (4), p.281-297

2019

Volltextzugriff (PDF)

NET-02: A multicenter, randomized, phase II trial of liposomal irinotecan (nal-IRI) and 5-fluorouracil (5-FU)/folinic acid or docetaxel as second-line therapy in patients (pts) with progressive poorly differentiated extra-pulmonary neuroendocrine carcinoma (PD-EP-NEC)

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.4005-4005

2022

Volltextzugriff (PDF)

Large cell neuroendocrine lung carcinoma: consensus statement from The British Thoracic Oncology Group and the Association of Pulmonary Pathologists

British journal of cancer, 2021-10, Vol.125 (9), p.1210-1216

2021

Volltextzugriff (PDF)

Analysis of Immune Landscape in Pancreatic and Ileal Neuroendocrine Tumours Demonstrates an Immune Cold Tumour Microenvironment

Neuroendocrinology, 2022-03, Vol.112 (4), p.370-383

2022

Volltextzugriff (PDF)

1 – 25 von 83

Suche als RSS-Feed

Aktive Filter

KollektionScienceDirect

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(68)
Mit Volltextzugriff
(59)

Publikationsform

Sprache

Englisch
(83)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The National Lung Matrix Trial of personalized therapy in lung cancer

The Effects of GCSF Primary Prophylaxis on Survival Outcomes and Toxicity in Patients with Advanced Non-Small Cell Lung Cancer on First-Line Chemoimmunotherapy: A Sub-Analysis of the Spinnaker Study

Clinically Significant Differences in Ki-67 Proliferation Index Between Primary and Metastases in Resected Pancreatic Neuroendocrine Tumors

Evaluating niraparib versus active symptom control in patients with previously treated mesothelioma (NERO): a study protocol for a multicentre, randomised, two-arm, open-label phase II trial in UK secondary care centres

Immunotherapy-related adverse events in real-world patients with advanced non-small cell lung cancer on chemoimmunotherapy: a Spinnaker study sub-analysis

Prognostic effect of body mass index in patients with advanced NSCLC treated with chemoimmunotherapy combinations

Newly qualified doctors' views about whether their medical school had trained them well: questionnaire surveys

Tumour diameter is not reliable for management of non-secreting pancreatic neuroendocrine tumours

'It gives you an understanding you can't get from any book.' The relationship between medical students' and doctors' personal illness experiences and their performance: a qualitative and quantitative study

Oncology and medical education-past, present and future

Explicitly linking teaching and assessment of communication skills

Outcome and Biomarker Analysis from a Multicenter Phase 2 Study of Ipilimumab in Combination with Carboplatin and Etoposide as First-Line Therapy for Extensive-Stage SCLC

A randomised phase II trial of niraparib versus active symptom control in patients with previously treated mesothelioma: NERO

The assessment of Ki-67 as a prognostic marker in neuroendocrine tumours: a systematic review and meta-analysis

THE COMPETENT NOVICE: Dealing with complaints

Utility of KI-67 as a prognostic biomarker in pulmonary neuroendocrine neoplasms: a systematic review and meta-analysis

Ethnic stereotypes and the underachievement of UK medical students from ethnic minorities: qualitative study

Easing the transition from student to doctor: How can medical schools help prepare their graduates for starting work?

NET-02 final results: A randomised, phase II trial of liposomal irinotecan (nal-IRI)/5-fluorouracil (5-FU)/folinic acid or docetaxel as second-line (2L) therapy in patients (pts) with progressive poorly differentiated extrapulmonary neuroendocrine carcinoma (PD-EP-NEC)

An open-label, multicenter phase I/IIa study evaluating the safety and clinical activity of clonal neoantigen reactive T cells in patients with advanced non-small cell lung cancer (CHIRON)

Recent advances in the molecular landscape of lung neuroendocrine tumors

Health-related quality of life (HRQoL) in patients (pts) with progressive, poorly differentiated, extra-pulmonary neuroendocrine carcinoma (PD-EP-NEC) enrolled in NET-02: A phase II trial of liposomal irinotecan (nal-IRI)/5-fluorouracil (5-FU)/folinic acid or docetaxel as second-line therapy

NET-02: A multicenter, randomized, phase II trial of liposomal irinotecan (nal-IRI) and 5-fluorouracil (5-FU)/folinic acid or docetaxel as second-line therapy in patients (pts) with progressive poorly differentiated extra-pulmonary neuroendocrine carcinoma (PD-EP-NEC)

Large cell neuroendocrine lung carcinoma: consensus statement from The British Thoracic Oncology Group and the Association of Pulmonary Pathologists

Analysis of Immune Landscape in Pancreatic and Ileal Neuroendocrine Tumours Demonstrates an Immune Cold Tumour Microenvironment

Aktive Filter

Suchergebnisse filtern